November 2001: Condition-Specific Supplement Markets I

In this 24-page issue, for the first time ever, NBJ looks at supplement sales according to health condition; analyzes Rx, OTC and supplement sales....

Excerpt from overview….

With 77 million or 28% of Americans now 50 and older, achy joints, hot flashes, indigestion and other symptoms of maturity are increasingly the subject of conversation. They are also increasingly the subject of requests for information here at Nutrition Business Journal: “How big is the market for menopause supplements? Joint care supplements? Colds and ’flu? Anti-Aging? Cholesterol support and heart health?

While historically NBJ has sized the supplement market according to product categories like herbs or vitamins and by sales channel like mass market or mail order, in this issue we break new ground by attempting to get our arms around supplement purchases by specific health conditions. The primary challenge of “condition-specific” research is that many supplements are useful for more than one health condition. For example, garlic might be used for gut health, heart health, immune health or all three. Similarly, when shoppers buy soy supplements, is their primary concern for heart heath, menopause or cancer prevention?

Following chart is one of the many detailed data breakdowns presented in this issue... copyright 2001, Penton Media Inc.

TABLE OF CONTENTS:

Condition-Specific Markets: NBJ looks at supplement sales according to health condition; analyzes Rx, OTC and supplement sales; invites opinion on supplement branding and condition-specific marketing...1-7

Chronic conditions become focus of Rx-to-OTC switching......8

Heart Health: Arkopharma, Enzymatic Therapy, Pharmavite, Twinlab and Wakunaga expand interest in cardiovascular category... 9-12

Women’s Health: Marketshare coalesces in fragmented market, featuring AmeriFit, GlaxoSmithKline, Novogen, Rainbow Light and Transitions for Health...13-17

IMAGINutrition reviews recent patents related to heart health, women’s health and gut health.........12,15,18

National Enzyme Company maintains good growth in gut health.....17-18

Pre- and Probiotics: Jarrow, Naturally Vitamins and New Chapter predict a strong future for gut health supplements...19-20

Q&A: Nutrition 21 reflects on experience in diabetes category...21-22

Leiner finds Body Benefits icons beneficial to business...23

Companies Featured Include:

American Heart Association, American Herbal Products Assn, American Pharmaceutical Association, AmeriFit Nutrition, Arkopharma, Baker-Dillon Public Relations, Bayer Corporation, Baylor College of Medicine, Chattem, Consultants Assn. for the Natural Products Industry, Consumer Healthcare Prod Assn, Council for Responsible Nutrition, Diabetes Research Working Gp, Dietary Supplement Education Alliance, Enzymatic Therapy, Federal Trade Commission, Forbes Medi-Tech, GlaxoSmithKline, Harris Interactive, Health from the Sun, IMAGINutrition, IMS Health, InterHealth Nutraceuticals Inc, Jarrow Formulas, Johnson & Johnson, LDI Group Inc., McNeil Consumer Healthcare, National Enzyme Company, National Institute for Health Care Management, National Nutritional Foods Assn, Naturally Vitamins, New Chapter, North American Menopause Assn, Novartis Consumer Health SA, Novogen Nutrition, Pharmacia, Pharmanex, Pharmavite, Rainbow Light, Retail Insights, Roper Starch Worldwide, Schaper & Brümer, SmithKlineBeecham, Spins, Standard Homeopathic Company, Sunsource, The Hartman Group, The Lake Group, The Natural Marketing Institute, Transitions for Health, TwinLab, Wakunaga of America, WellPoint Health Networks, Whitehall Robins 



BI 11.01$120.00

Condition Specific Healthcare Products Market Data
Individual Articles from November 2001 - Condition Specific Supplements Markets
Special Condition Specific Supplement Markets Package

 



Subscribe to NBJ and receive the industry's latest market data & strategic analysis every month. A subscription to NBJ is the equivalent of having your own in-house research deptartment!



Copyright © 2007 Penton Media, Inc.
tel: (303) 998.9399, fax: (303) 385.0046. All rights reserved. This website, or any part, may not be duplicated, stored in a retrieval system or transmitted in any form without prior written permission of the publisher. Unauthorized use of this information is illegal. Disclaimer: Although NBJ has made every effort to be accurate, errors may appear and are unintentional.